Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Germing

Showing results (171-180 of 339) with videos related to

Pageof 34
Sort By:
Journal of Geriatric Oncology|April 27, 2019
Comprehensive geriatric assessment predicts azacitidine treatment duration and survival in older patients with myelodysplastic syndromesAngela Molga, Michelle Wall, Rakchha Chhetri, et al.
Scientific Reports|April 8, 2025
The role of genetic testing in accurate diagnosis of X-linked sideroblastic anemia: novel ALAS2 mutations and the impact of X-chromosome inactivationDaniel Jové-Solavera, Marta Rámila, Xènia Ferrer-Cortés, et al.
Molecular & Cellular Proteomics : MCP|February 6, 2013
Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromesJulia Fröbel, Ron-Patrick Cadeddu, Sonja Hartwig, et al.
Annals of Hematology|November 20, 2017
Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study GroupThomas Schroeder, Christina Rautenberg, William Krüger, et al.
International Journal of Cancer|June 16, 2004
Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancerUlrich-Peter Rohr, Nina Rehfeld, Lucy Pflugfelder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplicationPeter Paschka, Richard F Schlenk, Verena I Gaidzik, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2026
High serum ferritin is associated with genetic instability in myelodysplastic neoplasmsChristina Ganster, Hannes Treiber, Gina Westhofen, et al.
Haematologica|September 7, 2012
Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trialKatja Sockel, Martin Bornhaeuser, Eva Mischak-Weissinger, et al.
International Journal of Hematology|January 20, 2009
Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndromeWolf C Prall, Akos Czibere, Franck Grall, et al.
Blood Advances|August 19, 2018
Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemiaBrian Ball, Rami S Komrokji, Lionel Adès, et al.
Pageof 34

Showing results (171-180 of 339) with videos related to

Sort By:
Pageof 34
Journal of Geriatric Oncology|April 27, 2019
Comprehensive geriatric assessment predicts azacitidine treatment duration and survival in older patients with myelodysplastic syndromesAngela Molga, Michelle Wall, Rakchha Chhetri, et al.
Scientific Reports|April 8, 2025
The role of genetic testing in accurate diagnosis of X-linked sideroblastic anemia: novel ALAS2 mutations and the impact of X-chromosome inactivationDaniel Jové-Solavera, Marta Rámila, Xènia Ferrer-Cortés, et al.
Molecular & Cellular Proteomics : MCP|February 6, 2013
Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromesJulia Fröbel, Ron-Patrick Cadeddu, Sonja Hartwig, et al.
Annals of Hematology|November 20, 2017
Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study GroupThomas Schroeder, Christina Rautenberg, William Krüger, et al.
International Journal of Cancer|June 16, 2004
Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancerUlrich-Peter Rohr, Nina Rehfeld, Lucy Pflugfelder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplicationPeter Paschka, Richard F Schlenk, Verena I Gaidzik, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2026
High serum ferritin is associated with genetic instability in myelodysplastic neoplasmsChristina Ganster, Hannes Treiber, Gina Westhofen, et al.
Haematologica|September 7, 2012
Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trialKatja Sockel, Martin Bornhaeuser, Eva Mischak-Weissinger, et al.
International Journal of Hematology|January 20, 2009
Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndromeWolf C Prall, Akos Czibere, Franck Grall, et al.
Blood Advances|August 19, 2018
Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemiaBrian Ball, Rami S Komrokji, Lionel Adès, et al.
Pageof 34